Crossmark

pH-responsive silica nanocarriers of olaparib for augmenting anticancer activity: development, characterization, and in vitro cytotoxicity study against MCF-7 breast cancer cells

Crossref DOI link: https://doi.org/10.1007/s13205-025-04364-9

Published Online: 2025-05-27

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gupta, Ankita https://orcid.org/0000-0001-8133-3736
Kushwaha, Swatantra K. S.

Mishra, Amit
License Information

Text and Data Mining valid from 2025-05-27

Version of Record valid from 2025-05-27
More Information

Article History

Received: 17 December 2024

Accepted: 16 May 2025

First Online: 27 May 2025

Declarations

:

: The authors declare no conflict of interest, financial or otherwise.

: None.

: Not applicable.

: No animals/humans were used for studies.

: Not applicable.

Document is current

Any future updates will be listed below